LCT
protein-codinglactase, the group of Glycoside hydrolase family 1
Gene summary
The protein encoded by this gene belongs to the glycosyl hydrolase 1 family of proteins. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme is integral to the plasma membrane and has both phlorizin hydrolase activity and lactase activity. Mutations in this gene are associated with congenital lactase deficiency. Polymorphisms in this gene are associated with lactase persistence, in which intestinal lactase activity persists at childhood levels into adulthood. [provided by RefSeq, Jan 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~49.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009115
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009115
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009115
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009115
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal
Intervention: Gastrointestinal
Rationale: Breast-feeding or lactose-containing formulas leads to severe osmotic diarrhea, which can be treated effectively with lactose-free diet
Comments: Upstream/noncoding variants may also result in adult-onset lactose intolerance
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LCT variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002299.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 344 | 2 | 352 | ||
| missense | 1 | 5 | 398 | 25 | 3 | 432 |
| nonsense | 12 | 6 | 1 | 19 | ||
| start loss | 0 | |||||
| frameshift | 19 | 6 | 3 | 28 | ||
| splice donor/acceptor (+/-2bp) | 1 | 6 | 1 | 8 | ||
| Total | 33 | 23 | 409 | 369 | 5 | 839 |
Highest pathogenic variant AF is 0.0003110335
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002290.2 | 17 | MANE Select | |
| Ensembl | ENSP00000264162.2 | 17 | MANE Select | |
| Ensembl | ENSP00000391231.1 | 6 | Standard | |
| Ensembl | ENSP00000795823.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Carbohydrate digestion and absorption - Homo sapiens (human)
- Galactose metabolism - Homo sapiens (human)
- Galactose Metabolism
- Galactosemia
- Lactose Degradation
Biological Process
- carbohydrate metabolic process
- polysaccharide digestion
Molecular Function
- lactase activity
- beta-glucosidase activity
- glycosylceramidase activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- membrane
- apical plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000264162
- Coding exons
- 17
- Length
- 49341
- Individuals with no LoFs
- 125462
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 285
- Defined
- 125748
- p
- 0.00114
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.16 | 771 | 1.06e+3 | 0.727 | 0.0000644 | 12719 |
| Missense (PolyPhen) | 160 | 376.37 | 0.42511 | 4669 | ||
| Synonymous | 0.313 | 437 | 445 | 0.981 | 0.0000307 | 3800 |
| Loss of Function | 6.19 | 19 | 78.0 | 0.244 | 0.00000415 | 851 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.010 | 0.010 | notable |
| European (Non-Finnish) | 0.00031 | 0.00031 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00081 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: LPH splits lactose in the small intestine.;
- Disease
- DISEASE: Congenital lactase deficiency (COLACD) [MIM:223000]: Autosomal recessive, rare and severe gastrointestinal disorder. It is characterized by watery diarrhea in infants fed with breast milk or other lactose-containing formulas. An almost total lack of LCT activity is found in jejunal biopsy material of patients with congenital lactase deficiency. Opposite to congenital lactase deficiency, also known as lactose intolerance, is the most common enzyme deficiency worldwide. It is caused by developmental down- regulation of lactase activity during childhood or early adulthood. The decline of lactase activity is a normal physiological phenomenon; however, the majority of Northern Europeans have the ability to maintain lactase activity and digest lactose throughout life (lactase persistence). The down-regulation of lactase activity operates at the transcriptional level and it is associated with a noncoding variation in the MCM6 gene, located in the upstream vicinity of LCT. {ECO:0000269|PubMed:16400612}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.666
Intolerance Scores
- LoFtool
- 0.571
- RVIS EVS
- -1.34
- RVIS percentile EVS
- 4.66
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.837
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |